US0109111056
US0109111056
Alamar Biosciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 |
|---|---|---|
Market & Enterprise Value | ||
Market Cap | 1.75B EUR | 1.88B EUR |
Enterprise Value | 1.6B EUR | 1.8B EUR |
Valuation Multiples | ||
Trailing P/E | -- | -- |
Forward P/E | -46.58x | -- |
Price to Sales | 17.46x | 22.19x |
Price to Book | 5.6x | 6.01x |
EV/Revenue | 15.93x | 21.23x |
EV/EBITDA | -42.67x | -- |
Price to FCF (P/FCF) | -- | -- |
EV/FCF | -- | -- |
FCF Yield | -- | -3.36% |